VYOME HOLDINGS, INC. Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
VYOME HOLDINGS, INC. (HIND) had Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance of 344 shares as of 2018-12-14, per its 8-K filed 2025-09-02.
Financial Statements › Notes › Compensation Related Costs › Deferred Compensation Arrangements
us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance · last filed 2025-09-02
- 2018-12-14: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 344.00 shares.
| Period end | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance |
|---|---|
| 2018-12-14 | 344.00 shares 8-K · filed 2025-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |